US Patent 10058599 Suppressor cell function inhibition following
Patent 10058599 was granted and assigned to Advaxis on August, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10058599 Suppressor cell function inhibition following
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.